Moreover, TET2 mutations are detected in B cells from AITL or other cancer patients, which may show a restricted repertoire of hyper-mutated IG genes94 and can harbor additional somatic mutations, notably in NOTCH136. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.